Innovation in science
Published: Thursday, April 15, 2010 - 08:42
in Health & Medicine
Results of a study presented today at the at the International Liver CongressTM 2010 reveals the effects of a new drug for the treatment of primary biliary cirrhosis, and shows further evaluation is necessary. INT-747 is a novel derivative of a human bile acid CDCA (that binds to the farnesoid-X receptor). In patients with PBC, addition of INT-747 to UDCA resulted in a significant amelioration of liver enzymes compared to placebo.
PBC is a chronic disease that damages bile ducts. Bile can no longer flow and builds up in the liver instead, damaging the liver cells and causing inflammation and scarring. This eventually leads to cirrhosis.
Source: European Association for the Study of the Liver
Articles on the same topic
- High dose UDCA therapy does not improve overall liver histology in obesity related hepatitisFri, 16 Apr 2010, 14:38:16 UTC
- New phase II study supports potential of gs-9450 as new treatment option for steatohepatitisFri, 16 Apr 2010, 14:38:15 UTC
- G1 HCV patients who achieve an early viral response can be successfully treated within 6 monthsFri, 16 Apr 2010, 14:38:14 UTC
- New insights into treatment options for patients suffering from severe alcoholic hepatitisFri, 16 Apr 2010, 14:38:00 UTC
- New studies help establish potential of artificial liver support devicesFri, 16 Apr 2010, 14:37:59 UTC
- Genetic signatures provide new direction in liver cancerFri, 16 Apr 2010, 13:29:15 UTC
- Clinical advancesFri, 16 Apr 2010, 12:19:32 UTC
- Study shows potential benefit of dark chocolate for liver disease patientsThu, 15 Apr 2010, 15:31:12 UTC
Other sources
- Genetic signatures provide new direction in liver cancerfrom Science BlogFri, 16 Apr 2010, 15:07:53 UTC
- New insights into treatment options for patients suffering from severe alcoholic hepatitisfrom Science BlogFri, 16 Apr 2010, 15:07:50 UTC
- New insights into treatment options for patients suffering from severe alcoholic hepatitisfrom PhysorgFri, 16 Apr 2010, 14:50:07 UTC
- New studies help establish potential of artificial liver support devicesfrom Science BlogFri, 16 Apr 2010, 14:29:06 UTC
- Genetic signatures provide new direction in liver cancerfrom PhysorgFri, 16 Apr 2010, 14:29:00 UTC
- Clinical advancesfrom Science BlogFri, 16 Apr 2010, 12:14:34 UTC
- Study shows potential benefit of dark chocolate for liver disease patientsfrom PhysorgThu, 15 Apr 2010, 19:18:42 UTC
- Potential benefit of dark chocolate for liver disease patientsfrom Science DailyThu, 15 Apr 2010, 16:09:40 UTC
- Innovation in sciencefrom Science BlogThu, 15 Apr 2010, 13:35:36 UTC